GO
Loading...

Express Scripts Holding Co

More

  • Final Glance: Drug Benefits companies Monday, 8 Sep 2014 | 6:38 PM ET

    NEW YORK— Shares of some top drug benefits companies were down at the close of trading:. CVSCaremark fell$. 24 or. 3 percent, to $81.40. Express Scripts Holding Co. fell$. 69 or. 9 percent, to $74.82.

  • Midday Glance: Drug Benefits companies Monday, 8 Sep 2014 | 1:36 PM ET

    NEW YORK— Shares of some top drug benefits companies are down at 1 p.m.:. CVS Health Corp. fell$. 02 or percent, to $81.62. Express Scripts Holding Co. fell$. 76 or 1.0 percent, to $74.75.

  • Early Glance: Drug Benefits companies Monday, 8 Sep 2014 | 10:34 AM ET

    NEW YORK— Shares of some top drug benefits companies are mixed at 10 a.m.:. CVS Health Corp. rose$. 20 or. 2 percent, to $81.84. Express Scripts Holding Co. fell$. 35 or. 5 percent, to $75.16.

  • Midday Glance: Drug Benefits companies Friday, 5 Sep 2014 | 3:45 PM ET

    NEW YORK— Shares of some top drug benefits companies are up at 1 p.m.:. CVSCaremark rose$. 78 or 1.0 percent, to $81.09. Express Scripts Holding Co. rose $2.12 or 2.9 percent, to $75.34.

  • Early Glance: Drug Benefits companies Friday, 5 Sep 2014 | 10:11 AM ET

    NEW YORK— Shares of some top drug benefits companies are up at 10 a.m.:. CVSCaremark rose$. 26 or. 3 percent, to $80.57. Express Scripts Holding Co. rose$. 59 or. 8 percent, to $73.81.

  • Final Glance: Drug Benefits companies Thursday, 4 Sep 2014 | 5:57 PM ET

    NEW YORK— Shares of some top drug benefits companies were down at the close of trading:. CVSCaremark fell$. 05 or. 1 percent, to $80.31. Express Scripts Holding Co. fell$. 45 or. 6 percent, to $73.22.

  • Midday Glance: Drug Benefits companies Thursday, 4 Sep 2014 | 1:16 PM ET

    NEW YORK— Shares of some top drug benefits companies are mixed at 1 p.m.:. CVSCaremark rose$. 07 or. 1 percent, to $80.43. Express Scripts Holding Co. fell$. 23 or. 3 percent, to $73.44.

  • Early Glance: Drug Benefits companies Thursday, 4 Sep 2014 | 10:26 AM ET

    NEW YORK— Shares of some top drug benefits companies are up at 10 a.m.:. CVSCaremark rose$. 58 or. 7 percent, to $80.94. Express Scripts Holding Co. rose$. 48 or. 7 percent, to $74.15.

  • *Advair restored to Express Scripts 2015 formulary list. LONDON, Aug 4- GlaxoSmithKline received a boost on Monday from a decision by Express Scripts, the largest U.S. pharmacy benefit manager, to reinstate its top-selling lung drug Advair as an approved drug in 2015..

  • Aug 1- Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, on Friday said it will remove 25 products from its 2015 list of preferred drugs, including anemia treatments Epogen and Aranesp, both sold by Amgen Inc..

  • Early movers: S, TWTR, AXP, GM, MAR, NFLX & more Wednesday, 30 Jul 2014 | 7:45 AM ET
    Traders work the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Express Scripts narrows full year forecast Tuesday, 29 Jul 2014 | 4:45 PM ET

    July 29- Express Scripts Holding Co, the largest pharmacy benefits manager in North America, posted a weaker profit and narrowed its full year forecast. Net profit fell to $522.7 million, or 67 cents per share, in the second quarter ended June 30, compared with $574.4 million, or 68 cents per share, a year earlier.

  • Summer's busiest week for markets is here Friday, 25 Jul 2014 | 6:10 PM ET
    Traders work on the floor of the New York Stock Exchange (NYSE) on Friday.

    A crush of big cap earnings and arguably the most important economic reports until September make next week the busiest of the summer for markets.

  • Sovaldi—$55 billion headache for states Thursday, 17 Jul 2014 | 10:18 AM ET

    States may be on the hook for $55 billion to pay for hepatitis C treatments like Sovaldi, a new study says.

  • A year of winners (and losers) post-'Alpha' Friday, 11 Jul 2014 | 6:34 AM ET
    Leon Cooperman, Chairman and CEO of Omega Advisors

    Some of 2014's biggest winners are slated to share their next big ideas at this year's Delivering Alpha Conference.

  • Why it may be harder to get customized drugs Thursday, 3 Jul 2014 | 12:31 PM ET
    Express Scripts Inc.'s headquarters stands in St. Louis, Missouri.

    The largest U.S. pharmacy benefit manager, Express Scripts, is cutting back on compounded medications, saying most are ineffective or overpriced.

  • They really delivered Alpha. But can they repeat? Monday, 16 Jun 2014 | 10:11 AM ET

    A combination of choppy markets and mixed investment successes promise to make this year's "Delivering Alpha" conference colorful.

  • FACTBOX-RPT-Paying for Sovaldi in the United States Wednesday, 28 May 2014 | 7:00 AM ET

    *Commercial insurers and Medicare Part D providers such as Express Scripts accounted for 90 percent of the more than $2 billion spent on Sovaldi in the United States during the first quarter, according to Gilead.

  • TIMELINE-Early signs of pushback over U.S. drug prices Wednesday, 28 May 2014 | 1:00 AM ET

    May 28- Gilead Sciences' $84,000 treatment for hepatitis C, Sovaldi, has broken the sales record for drug launches and caused a backlash among insurers concerned by the cost.

  • FACTBOX-Paying for Sovaldi in the United States Wednesday, 28 May 2014 | 1:00 AM ET

    *Commercial insurers and Medicare Part D providers such as Express Scripts accounted for 90 percent of the more than $2 billion spent on Sovaldi in the United States during the first quarter, according to Gilead.